Showing results (81-90 of 98) with videos related to
Sort By:
Pageof 10
Neurochemical Research|May 31, 2024
ACKR3 Antagonism Enhances the Repair of Demyelinated Lesions Through Both Immunomodulatory and Remyelinating EffectsLaetitia Pouzol, Anna Sassi, Mélanie Tunis, et al.Clinical Pharmacology and Therapeutics|January 6, 2021
A Multipurpose First-in-Human Study With the Novel CXCR7 Antagonist ACT-1004-1239 Using CXCL12 Plasma Concentrations as Target Engagement BiomarkerChristine Huynh, Andrea Henrich, Daniel S Strasser, et al.Nature Communications|August 21, 2024
Limb reduction in an Esco2 cohesinopathy mouse model is mediated by p53-dependent apoptosis and vascular disruptionArielle S Strasser, Ana Silvia Gonzalez-Reiche, Xianxiao Zhou, et al.Clinical and Experimental Immunology|July 17, 2023
Combination treatment of a novel CXCR3 antagonist ACT-777991 with an anti-CD3 antibody synergistically increases persistent remission in experimental models of type 1 diabetesUrs Christen, Laetitia Pouzol, Mélanie Tunis, et al.Experimental Lung Research|January 12, 2018
Granulomatous lung inflammation is nanoparticle type-dependentYves Pacheco, Marine Ponchon, Serge Lebecque, et al.The Lancet. Rheumatology|November 25, 2024
Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trialAnca D Askanase, David D'Cruz, Kenneth Kalunian, et al.Molecular Genetics and Metabolism Reports|March 4, 2022
Plasma neurofilament light, glial fibrillary acidic protein and lysosphingolipid biomarkers for pharmacodynamics and disease monitoring of GM2 and GM1 gangliosidoses patientsRichard W D Welford, Herve Farine, Michel Steiner, et al.Journal of Medicinal Chemistry|January 26, 2010
Low molecular weight antagonists of the myelin-associated glycoprotein: synthesis, docking, and biological evaluationStefanie Mesch, Delia Moser, Daniel S Strasser, et al.The Journal of Pharmacology and Experimental Therapeutics|January 10, 2019
Pharmacological Characterization of Aprocitentan, a Dual Endothelin Receptor Antagonist, Alone and in Combination with Blockers of the Renin Angiotensin System, in Two Models of Experimental HypertensionFrederic Trensz, Céline Bortolamiol, Markus Kramberg, et al.Cell Death and Differentiation|September 13, 2003
Subcellular localisation of Cdc25A determines cell fateC Leisser, G Rosenberger, S Maier, et al.Pageof 10